A novel application of plasma and cerebrospinal fluid level of Epstein Barr virus DNA in the diagnosis of leptomeningeal metastasis from nasopharyngeal carcinoma: A case report

Oncology

Volumn 74, Issue 1-2, 2008, Pages 119-122

  Ma, Ada T W ^a   Ma, Brigette B Y ^a   Teo, Peter M L ^a   Chan, Anthony T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerebrospinal fluid DNA; Epstein Barr virus; Leptomeningeal metastasis; Nasopharyngeal carcinoma; Plasma DNA

Indexed keywords

CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; GEMCITABINE; PACLITAXEL; STEROID; VIRUS DNA;

ADULT; ANAMNESIS; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; DRUG MEGADOSE; EPSTEIN BARR VIRUS; HUMAN; MALE; MENINGEAL METASTASIS; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BIOPSY;

ADULT; DNA, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MENINGEAL NEOPLASMS; NASOPHARYNGEAL NEOPLASMS;

EID: 46249127052     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000139140     Document Type: Article

References (15)

1. Rickinson AB, Kieff E: Epstein-Barr virus;in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, Lippincott-Raven, 1996, pp 2397-2446.
2. Ho JHC: An epidemiological and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978;4:183-198.
3. Chan KCA, Lo YMD: Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:489-496.
4. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M: AJCC Cancer Staging Manual, ed 6. New York, Springer, 2002.
5. Lo YM, Chan LY, Lo KW, Leung SF, Zhang J, Chan AT, Lee JC, Hjelm NM, Johnson PJ, Huang DP: Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999;59:1188-1191.
6. DeAngelis LM, Boutros D: Leptomeningeal metastasis. Cancer Invest 2005;23:145-154.
7. Cvitkovic E, Bachouchi M, Boussen H, Busson P, Rousselet G, Mahjoubi R, Flores P, Tursz T, Armand JP, Azli N: Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type. A review of 255 consecutive cases. J Clin Oncol 1993;11:2434-2442.
8. Redman BG, Tapazoglou E, Al-Sarraf M: Meningeal carcinomatosis in head and neck cancer. Report of six cases and review of the literature. Cancer 1986;58:2656-2661.
9. Wang CJ, Wang CY: Nasopharyngeal carcinoma with leptomeningeal dissemination: case report. Chang Gung Med J 2000;23:118-122.
10. Lee O, Cromwell LD, Weider DJ: Carcinomatous meningitis arising from primary nasopharyngeal carcinoma. Am J Otolaryngol 2005;26:193-197.
11. Ngan RKC, Yiu HHY, Cheng HKM, Chan JKC, Sin VC, Lau WH: Central nervous system metastasis from nasopharyngeal carcinoma. A report of two patients and a review of the literature. Cancer 2002;94:398-405.
12. Wasserstrom W, Glass J, Posner J: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759-772.
13. Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995;38:51-57.
14. Yen RF, Hong RL, Tzen KY, Pan MH, Chen TH: Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma. J Nucl Med 2005;46:770-774.
15. Davey P: Brain metastases: treatment options to improve outcomes. CNS Drugs 2002;16:325-338.